Literature DB >> 15041894

Alcohol-induced liver disease: when fat and oxidative stress meet.

José C Fernández-Checa1.   

Abstract

Reactive oxygen species (ROS) act as signaling intermediates regulating multiple cellular processes. The fate and disposal of the signaling species are determined by the actions of antioxidants, particularly glutathione (GSH). The mitochondrial pool of GSH (mGSH) arises from the transport of cytosol GSH by a specific mitochondrial carrier and is responsible for the maintenance of a healthy competent organelle. The depletion of mGSH upon impairment of the mitochondrial transport activity leaves mitochondria unprotected from damaging effects of ROS overgeneration within the mitochondrial electron transport chain. Tumor necrosis factor-alpha (TNF-alpha) has emerged as a key player in the progression of the alcohol-induced liver disease (ALD), and is known to target mitochondria. Key components of TNF signaling include sphingolipids, particularly ceramide generated from acidic sphingomyelinase activation serving as a source for gangliosides. In experimental models alcohol consumption enhances cholesterol levels and subsequent deposition into mitochondria resulting in selective decrease in the mGSH stores which is sufficient by itself to sensitize hepatocytes to TNF-alpha-mediated cell death. Thus, the combination of TNF-alpha overproduction, enhanced glycosphingolipid generation and selective mGSH depletion by alcohol intake cooperate making the liver sensitive to alcohol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15041894

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  9 in total

Review 1.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

2.  Brain mitochondrial alterations after chronic alcohol consumption.

Authors:  I Almansa; A Fernández; C García-Ruiz; M Muriach; J M Barcia; M Miranda; J C Fernández-Checa; F J Romero
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

3.  Accumulation of long-chain glycosphingolipids during aging is prevented by caloric restriction.

Authors:  María José Hernández-Corbacho; Russell W Jenkins; Christopher J Clarke; Yusuf A Hannun; Lina M Obeid; Ashley J Snider; Leah J Siskind
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

4.  Chronic Glutathione Depletion Confers Protection against Alcohol-induced Steatosis: Implication for Redox Activation of AMP-activated Protein Kinase Pathway.

Authors:  Ying Chen; Surendra Singh; Akiko Matsumoto; Soumen K Manna; Mohamed A Abdelmegeed; Srujana Golla; Robert C Murphy; Hongbin Dong; Byoung-Joon Song; Frank J Gonzalez; David C Thompson; Vasilis Vasiliou
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

5.  Co-administration of sodium arsenite and ethanol: Protection by aqueous extract of Aframomum longiscapum seeds.

Authors:  Solomon E Owumi; Oyeronke A Odunola; Mohammed Aliyu
Journal:  Pharmacognosy Res       Date:  2012-07

6.  Naltrexone reverses ethanol-induced rat hippocampal and serum oxidative damage.

Authors:  Inmaculada Almansa; Jorge M Barcia; Rosa López-Pedrajas; María Muriach; María Miranda; Francisco Javier Romero
Journal:  Oxid Med Cell Longev       Date:  2013-12-01       Impact factor: 6.543

Review 7.  Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.

Authors:  Yasuko Iwakiri
Journal:  Clin Mol Hepatol       Date:  2015-12-24

8.  Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice.

Authors:  Jason Correnti; Chelsea Lin; Jascha Brettschneider; Amy Kuriakose; Sookyoung Jeon; Eleonora Scorletti; Amanke Oranu; Dru McIver-Jenkins; Isabelle Kaneza; Delfin Buyco; Yedidya Saiman; Emma E Furth; Josepmaria Argemi; Ramon Bataller; William L Holland; Rotonya M Carr
Journal:  J Lipid Res       Date:  2020-05-12       Impact factor: 5.922

9.  Investigating RNA expression profiles altered by nicotinamide mononucleotide therapy in a chronic model of alcoholic liver disease.

Authors:  Mohammed A Assiri; Hadi R Ali; John O Marentette; Youngho Yun; Juan Liu; Matthew D Hirschey; Laura M Saba; Peter S Harris; Kristofer S Fritz
Journal:  Hum Genomics       Date:  2019-12-10       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.